Press release
Monoamine Oxidase (MAO) Inhibitor Drugs Market Analysis 2019 Top companies are Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline plc., Merck & Co., Inc
Monoamine Oxidase (MAO) Inhibitor Drugs Market
Market Analysis:
Global monoamine oxidase (MAO) inhibitor drugs market is rising gradually with a substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Untapped emerging economies and competitive scenario of market and strategic collaborations are factors contributing positively towards the growth of this market.
Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-monoamine-oxidase-mao-inhibitor-drugs-market
Key Market Players:
Few of the major competitors currently working in the global monoamine oxidase (MAO) inhibitor drugs market are Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline plc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Bausch Health, Eli Lilly and Company, Orchid Chemicals & Pharamaceuticals Ltd., Validus Pharmaceuticals LLC, INDOCO REMEDIES LTD., Teikoku Pharma USA, Inc., H. Lundbeck A/S, Alliance Pharma PLC, AstraZeneca, Johnson & Johnson Services, Inc., Gedeon Richter Plc., Luye Pharma Group, Bristol-Myers Squibb Company, CeNeRx BioPharma, Inc. among others.
Key Developments in the Market:
In June 2017, Takeda Pharmaceutical Company Limited submitted a New Drug Application to the Ministry of Health, Labour and Welfare in Japan for rasagiline mesylate (TVP-1012), a selective irreversible monoamine oxidase type-B (MAO-B) inhibitor used for treatment for patients with Parkinson’s disease. Rasagiline mesylate is already developed by Teva Pharmaceutical Industries Ltd. and approved in the United States and Europe. If approved, it will enhance the product availability and helps patient through cost-effective treatment throughout Japan
In June 2017, Mylan N.V. launched Rasagiline which is generic version of Azilect for the treatment of Parkinson’s disease in the United States. The launch of rasagiline, provides the cost-effective treatment to the patients suffering from the Parkinson’s disease in the United States as well as broadens the company’s generic portfolio in the therapeutic area of CNS.
Global Monoamine Oxidase (MAO) Inhibitor Drugs Market By Types (MAO-A Inhibitor, MAO-B Inhibitor), Drugs (Isocarboxazid, Phenelzine, Tranylcypromine, Others), Disorder Type (Parkinson’s Disease, Depression, Anxiety, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026
Competitive Analysis:
Global monoamine oxidase (MAO) inhibitor drugs market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of monoamine oxidase (MAO) inhibitor drugs market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Market Definition: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market
Monoamine Oxidase (MAO) Inhibitors are the drugs that are used for treatment of depression. It works by prevention of breakdown of serotonin, dopamine, and norepinephrine in CNS and maintains their availability. These inhibitors possess huge risk of distributing other neurotransmitters in the brain and digestive system causing side effects. The major side effects of MAO inhibitors are high blood pressure, insomnia and weight gain.
The administration of MAO inhibitor drugs has been decreased in several years. During the year 1997 to 2006, the incidence rate of MAO inhibitors prescriptions has fallen from 3.1 per 100,000 to 1.4 per 100,000.
Table Of Content: Monoamine Oxidase (MAO) Inhibitor Drugs Market
Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Monoamine Oxidase (MAO) Inhibitor Drugs Market
Part 04: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Sizing
Part 05: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market Segmentation By Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers And Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Continue….
Market Drivers
Increasing patient pool of depression disorders worldwide acts as a driving factor for this market growth
Increasing government initiatives to spread awareness about the mental health among people will also boost the market growth in the forecast period
Rising geriatric population that are highly prone to have mental health issues will expand the market size
Surge of development of novel drugs and techniques with fewer side-effects will drive the market growth
Market Restraints
Side effects associated with MAO inhibitor are expected to restrain the market growth
Poor efficacy and safety profiles of the drug hampers the market growth
Increase in patent expiration of antidepressant drugs is weakening the pipeline; this factor will also restrict the growth of this market
Grab Your Report at an Impressive 30% Discount! Please click Here@https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-monoamine-oxidase-mao-inhibitor-drugs-market
Segmentation: Global Monoamine Oxidase (MAO) Inhibitor Drugs Market
By Types
MAO-A Inhibitor
MAO-B Inhibitor
Drugs
Isocarboxazid
Phenelzine
Tranylcypromine
Others
By Disorder Type
Parkinson’s Disease
Depression
Anxiety
Others
By End Users
Hospitals
Homecare
Specialty Clinics
Others
By Distribution Channels
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Others
Reasons to Purchase this Report
Current and future of global monoamine oxidase (MAO) inhibitor drugs market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
The report provides insights on the following points:
Learn about the market strategies that are being adopted by your competitors and leading organizations
Market Penetration: Comprehensive information on the product portfolios of the top players in the market
To gain insightful analyses of the market and have a comprehensive understanding of the “Monoamine Oxidase (MAO) Inhibitor Drugs Market ” and its commercial landscape
To understand the future outlook and prospects for Monoamine Oxidase (MAO) Inhibitor Drugs Market analysis and forecast 2019-2026.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Monoamine Oxidase (MAO) Inhibitor Drugs Market Analysis 2019 Top companies are Takeda Pharmaceutical Company Limited, Mylan N.V., GlaxoSmithKline plc., Merck & Co., Inc here
News-ID: 1886442 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for MAO
Methylaluminoxane (MAO) Market Size, Historical Growth, Analysis, Opportunities …
Los Angeles, United State: The global Methylaluminoxane (MAO) market is comprehensive and accurately presented in the report with the help of detailed market information and data, critical findings, error-free statistics, and reliable forecasts. The report digs deep into important aspects of the global Methylaluminoxane (MAO) market, including competition, segmentation, regional expansion, and market dynamics. Each leading trend of the global Methylaluminoxane (MAO) market is carefully studied and elaborately presented in…
Monoamine Oxidase (MAO) Inhibitor Drugs Market Current and Future Trend Scenario …
By employing definite steps to collect, record, and analyse market data, the top notch Monoamine Oxidase (MAO) Inhibitor Drugs market research report has been prepared. In addition to detailing about competitive landscape of the key players, this report also offers complete and distinct analysis of the market drivers and restraints, detailed analysis of the market segmentation, key developments in the market and details of research methodology. This market report helps…
Methylaluminoxane (MAO) Market New Study Offers Insights for 2028 | Friend Chemi …
This Methylaluminoxane (MAO) market analysis report reveals regional profit margins for leading regions. The methods to develop, progress and enhance the performance of the organization are also presented here. Material covered in this market research is the result of the diligent attempt of researchers to offer accurate data to key stakeholders. It consists of a regulatory scenario, human statistics and competitive analysis to display and monitor market competition. The impact…
Latest Methylaluminoxane (MAO) Market 2022 | Detailed Report
According to Market Study Report, Methylaluminoxane (MAO) Market provides a comprehensive analysis of the Methylaluminoxane (MAO) Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5414936
The report provides a comprehensive analysis of company profiles listed below:
- Albemarle
- Akzo Nobel
- Lanxess
- Tosoh Finechem
-…
Global Methylaluminoxane (MAO) Market Insights, Forecast to 2025
Global Methylaluminoxane (MAO) Market report is designed in a method that helps readers to acquire a complete knowledge about the overall market scenario for the projected period. This Market report consists of the brief profile of key players in the industry and their upcoming market plans and current developments during the forecasted period 2019 to 2025.
The report of global Methylaluminoxane (MAO) market includes the competitive landscape section which provides the full and in-depth…
Future Growth: Global Bromelain Market By Key Players: Enzybel Intl., Hong Mao B …
Qyresearchreports include new market research report Bromelain to its huge collection of research reports.
This report studies the global Bromelain market status and forecast, categorizes the global Bromelain market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Bromelain market is…
